CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2026; 10: (1) ; 98-100 ; DOI: 10.12208/j.ijcr.20260027.

Analysis of related factors of recurrence in patients with hyperthyroidism after drug withdrawal in the early stage of pregnancy and its impact on pregnancy outcomes
甲亢患者妊娠早期停药后复发的相关因素及对妊娠结局的影响分析

作者: 农冠良 *

广西壮族自治区妇幼保健院 广西南宁

*通讯作者: 农冠良,单位:广西壮族自治区妇幼保健院 广西南宁;

发布时间: 2026-01-29 总浏览量: 27

摘要

目的 探究甲亢患者妊娠早期停药后复发的相关因素及对妊娠结局的影响。方法 选取本院甲亢妊娠早期停药患者94例,时间2024年6月—2025年6月,根据患者复发情况,分为复发组(36例)和未复发组(58例),对患者复发的相关因素及对妊娠结局的影响进行回顾性分析。结果 年龄、甲亢病程、甲状腺功能指标、甲状腺自身抗体、家族史等因素,均会对甲亢患者妊娠早期停药后复发造成影响,同时复发组不良妊娠结局发生率高于未复发组,差异有统计学意义(P<0.05)。结论 针对甲亢患者妊娠早期停药后复发问题,需基于高危因素,制定个体化干预策略,以控制复发问题,改善妊娠结局。

关键词: 甲亢;妊娠早期停药;复发;相关因素;妊娠结局

Abstract

Objective To explore the related factors of recurrence in patients with hyperthyroidism after drug withdrawal in the early stage of pregnancy and its impact on pregnancy outcomes.
Methods A total of 94 patients with hyperthyroidism who discontinued medication in the early stage of pregnancy in our hospital were selected from June 2024 to June 2025. According to the recurrence situation of the patients, they were divided into the recurrence group (36 cases) and the non-recurrence group (58 cases). A retrospective analysis was conducted on the related factors of recurrence and their impact on pregnancy outcomes.
Results Factors such as age, duration of hyperthyroidism, thyroid function indicators, thyroid autoantibodies, and family history all have an impact on the recurrence of hyperthyroidism patients after drug withdrawal in the early stage of pregnancy. Meanwhile, the incidence of adverse pregnancy outcomes in the recurrence group was higher than that in the non-recurrence group, and the difference was statistically significant (P < 0.05).
Conclusion   For the recurrence problem of hyperthyroidism patients after drug withdrawal in the early stage of pregnancy, individualized intervention strategies should be formulated based on high-risk factors to control the recurrence problem and improve pregnancy outcomes.

Key words: Hyperthyroidism; Discontinuing medication in the early stage of pregnancy; Recurrence; Relevant factors; Pregnancy outcome

参考文献 References

[1] 刘红冬.丙硫氧嘧啶与甲巯咪唑治疗妊娠合并甲状腺功能亢进的效果比较[J].大医生,2025,10(19):138-141.

[2] 化强,刘杏丽,徐卫敏.丙硫氧嘧啶片和甲巯咪唑片治疗妊娠合并甲状腺功能亢进的临床疗效及对患者促甲状腺激素受体抗体甲状腺过氧化物酶抗体水平的影响[J].中国妇幼保健,2025,40(13):2379-2383.

[3] 韩晓慧,王丹,李莉.六位一体护理合作模式在妊娠合并甲状腺功能亢进症患者中的应用效果[J].医学临床研究,2025,42(6):1081-1083.

[4] 刘萍.甲状腺功能异常与血脂代谢及妊娠结局的关系[J].中国城乡企业卫生,2025,40(6):156-158.

[5] 李慧,于晓晴,刘作侠.妊娠合并甲状腺功能异常患者子代甲状腺功能评估[J].中国妇幼健康研究,2025,36(1): 64-68.

[6] 秦雯文,潘平山,邱文文,等.1例甲亢继发甲减的妊娠患者伴胎儿甲亢的用药护理[J].内科,2024,19(3):345-348.

[7] 熊烨,邹颖,胡丽娟.不同剂量丙硫氧嘧啶治疗妊娠合并甲亢的效果分析[J].中国医学创新,2024,21(16):136-140.

[8] 吴欣瑜,高原,邹箭锋,等.丙基硫氧嘧啶治疗妊娠合并甲亢对患者凝血功能、母婴结局影响[J].中国计划生育学杂志,2023,31(11):2606-2610+2614.


引用本文

农冠良, 甲亢患者妊娠早期停药后复发的相关因素及对妊娠结局的影响分析[J]. 国际临床研究杂志, 2026; 10: (1) : 98-100.